Similar articles

• Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?

  Azzoli CG. Azzoli CG. Nat Clin Pract Oncol. 2005 Nov;2(11):552-3. doi: 10.1038/ncponc0350. Nat Clin Pract Oncol. 2005. PMID: 16270095 Clinical Trial. No abstract available.
• Treatment of resected non-small-cell lung cancer.

  Bria E, Giannarelli D, Terzoli E. Bria E, et al. N Engl J Med. 2005 Oct 6;353(14):1523-4; author reply 1523-4. doi: 10.1056/NEJMc052019. N Engl J Med. 2005. PMID: 16207858 No abstract available.
• Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?

  Besse B, Le Chevalier T. Besse B, et al. J Clin Oncol. 2008 Nov 1;26(31):5014-7. doi: 10.1200/JCO.2008.18.1081. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809602 No abstract available.
• [New trends in adjuvant chemotherapy for non-small-cell lung cancer].

  Dediu M, Alexandru A, Median D, Vremeş G. Dediu M, et al. Pneumologia. 2005 Apr-Jun;54(2):89-93. Pneumologia. 2005. PMID: 16536008 Review. Romanian. No abstract available.
• The current status of adjuvant chemotherapy for resected non-small cell lung cancer.

  Socinski MA. Socinski MA. Semin Oncol. 1999 Oct;26(5 Suppl 15):27-33. Semin Oncol. 1999. PMID: 10566608 Review.